Last reviewed · How we verify
Diazepam Nasal Spray [Valtoco]
Diazepam Nasal Spray [Valtoco] is a Small molecule drug developed by Neurelis, Inc.. It is currently in Phase 1 development.
At a glance
| Generic name | Diazepam Nasal Spray [Valtoco] |
|---|---|
| Sponsor | Neurelis, Inc. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Diazepam Nasal Spray [Valtoco] CI brief — competitive landscape report
- Diazepam Nasal Spray [Valtoco] updates RSS · CI watch RSS
- Neurelis, Inc. portfolio CI
Frequently asked questions about Diazepam Nasal Spray [Valtoco]
What is Diazepam Nasal Spray [Valtoco]?
Diazepam Nasal Spray [Valtoco] is a Small molecule drug developed by Neurelis, Inc..
Who makes Diazepam Nasal Spray [Valtoco]?
Diazepam Nasal Spray [Valtoco] is developed by Neurelis, Inc. (see full Neurelis, Inc. pipeline at /company/neurelis-inc).
What development phase is Diazepam Nasal Spray [Valtoco] in?
Diazepam Nasal Spray [Valtoco] is in Phase 1.
Related
- Manufacturer: Neurelis, Inc. — full pipeline
- Compare: Diazepam Nasal Spray [Valtoco] vs similar drugs
- Pricing: Diazepam Nasal Spray [Valtoco] cost, discount & access